The epithelium in idiopathic pulmonary fibrosis: breaking the barrier.
about
Macrophage and Innate Lymphoid Cell Interplay in the Genesis of FibrosisAn Epithelial Integrin Regulates the Amplitude of Protective Lung Interferon Responses against Multiple Respiratory PathogensThe Telomere/Telomerase System in Chronic Inflammatory Diseases. Cause or Effect?Active transforming growth factor-β is associated with phenotypic changes in granulomas after drug treatment in pulmonary tuberculosisA Comparison of Gene Expression Profiles between Glucocorticoid Responder and Non-Responder Bovine Trabecular Meshwork Cells Using RNA SequencingLong-term intravenous administration of carboxylated single-walled carbon nanotubes induces persistent accumulation in the lungs and pulmonary fibrosis via the nuclear factor-kappa B pathwayProtein kinase D is increased and activated in lung epithelial cells and macrophages in idiopathic pulmonary fibrosis.Selective targeting of alveolar type II respiratory epithelial cells by anti-surfactant protein-C antibody-conjugated lipoplexesAstragalin inhibits autophagy-associated airway epithelial fibrosis.A Mathematical Model of Idiopathic Pulmonary Fibrosis.Enolase 1 (ENO1) and protein disulfide-isomerase associated 3 (PDIA3) regulate Wnt/β-catenin-driven trans-differentiation of murine alveolar epithelial cells.CTGF siRNA ameliorates tubular cell apoptosis and tubulointerstitial fibrosis in obstructed mouse kidneys in a Sirt1-independent manner.Extracellular matrix assembly: a multiscale deconstructionCaMKII inhibition in type II pneumocytes protects from bleomycin-induced pulmonary fibrosis by preventing Ca2+-dependent apoptosis.Inhibitory effects of amines from Citrus reticulata on bleomycin-induced pulmonary fibrosis in rats.Transcriptional control of cardiac fibroblast plasticity.Targeted Type 2 Alveolar Cell Depletion. A Dynamic Functional Model for Lung Injury Repair.Computational Modeling Predicts Simultaneous Targeting of Fibroblasts and Epithelial Cells Is Necessary for Treatment of Pulmonary Fibrosis.Attenuation of lung fibrosis in mice with a clinically relevant inhibitor of glutathione-S-transferase π.Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis.The role of club cell phenoconversion and migration in idiopathic pulmonary fibrosis.A Systematic Review of the Role of Dysfunctional Wound Healing in the Pathogenesis and Treatment of Idiopathic Pulmonary Fibrosis.Galectin-1 inhibition attenuates profibrotic signaling in hypoxia-induced pulmonary fibrosisIntegrins and cadherins as therapeutic targets in fibrosis.Promising new treatment targets in patients with fibrosing lung disorders.Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis.Radiation induced pulmonary fibrosis as a model of progressive fibrosis: Contributions of DNA damage, inflammatory response and cellular senescence genes.The TNF Family Molecules LIGHT and Lymphotoxin αβ Induce a Distinct Steroid-Resistant Inflammatory Phenotype in Human Lung Epithelial Cells.The SPARC protein: an overview of its role in lung cancer and pulmonary fibrosis and its potential role in chronic airways disease.Meprin β contributes to collagen deposition in lung fibrosis.Plasma membrane wounding and repair in pulmonary diseases.BRD4 mediates NF-κB-dependent epithelial-mesenchymal transition and pulmonary fibrosis via transcriptional elongation.Epithelial-to-mesenchymal transition and its role in EGFR-mutant lung adenocarcinoma and idiopathic pulmonary fibrosis.Reduced transforming growth factor β1 (TGF-β1) in the repair of airway epithelial cells of children with asthma.IPF: Moving from Idiopathic to Infectious Pulmonary Fibrosis?1α,25-dihydroxyvitamin D3 Attenuates TGF-β-Induced Pro-Fibrotic Effects in Human Lung Epithelial Cells through Inhibition of Epithelial-Mesenchymal Transition.Identifying Mechanisms of Homeostatic Signaling in Fibroblast Differentiation.Permanent alveolar collapse is the predominant mechanism in idiopathic pulmonary fibrosis.Rapamycin increases CCN2 expression of lung fibroblasts via phosphoinositide 3-kinase.Fibroblastic foci, covered with alveolar epithelia exhibiting epithelial-mesenchymal transition, destroy alveolar septa by disrupting blood flow in idiopathic pulmonary fibrosis.
P2860
Q26774652-DD1E9AC8-832E-40B2-933B-B86FEB49E672Q27312333-F59678EF-0210-402F-B31B-9A03CB1351F5Q28077460-5EEEBEC6-C280-463E-AD19-333E9AEB67B3Q28393653-1203840A-E505-4D11-8D80-2E8820029E4FQ28469378-87931D04-1C22-445F-9277-90B4A0F1939EQ29247884-A3CA39CA-AE2A-46AE-ABBB-BDB21BC9E965Q33856238-54E34E44-D497-48BD-85B9-AA822EBEAF4FQ35434883-4A106E46-1896-4946-BFAA-E880EFF2A01EQ35523153-1370FD28-2360-4F42-BC8A-90AF4EB52A82Q35766783-5971983F-2029-4078-BA09-551DFB44204DQ35923444-2CB04F11-A4FA-4512-B392-8F028205AEFEQ35923790-3B0C6167-F705-4311-AE18-9520DFFAFEE5Q36381030-39A98FFD-62EA-4812-9CA6-749BD661CBB8Q36422643-51D876A4-05EC-42D3-A8DD-943AD0F18195Q36473707-B5D3C960-8D0D-421F-A9CD-35E5FCF28336Q36609712-12BC43F3-3A5C-416B-A6FA-9EA4E11C13F6Q36765882-137739EE-0BB5-4FEC-8EA3-5747ACF31BE8Q37030035-91474E93-A7C6-461C-A179-0802E3726C39Q37041521-6804FB03-32D9-4BED-9AAE-C739DEF9B815Q37469191-82B401FB-ADDB-4E37-B792-885AB08D6E6DQ37538264-208B991A-CE4B-4F6F-83AD-614FAA1689EFQ37628170-A1CB88EA-685B-4F1D-A03A-3E1745AB2A85Q37743018-7E17F16C-0D3C-4F06-B635-AEA5DA087EE9Q38219401-5B006989-06C8-4731-95D8-A2DDE7075D82Q38269057-AC110F93-5309-4143-B5A8-9C2B758FE7C8Q38432028-899CC591-4201-4341-87EE-6F5E33573226Q38769339-55C127F2-917D-4FC4-AC30-909AF6AA675EQ38849456-D598E07C-2FB6-4A10-8BBB-ACB4D6949FE0Q38985417-3F5962CB-5D0B-422E-B42A-4C27D6D18127Q39036654-5995CB37-362C-4A27-8DBC-3E8A9AC49A80Q39071297-626CAD8B-860A-445F-BF9E-9E39F5725A9AQ39236663-A76E54F3-0EFF-48E6-AC8A-17B64497A50FQ39415339-D5DC2865-D602-4349-AC3C-F27D2AC30A63Q39738881-F027C049-4C72-4CF3-B7C7-290861DAB008Q40134859-27363551-3967-4D0D-9501-3379240D3166Q41902905-9777571B-D10A-4517-9D42-8DEA464EFE08Q41949357-295B0C7D-1F37-44D2-9F4C-7E19EE8227E8Q42479603-9C891441-1506-469B-9EF2-DAEB900DC1FCQ42479992-4FBA6FB3-D43B-4CCD-965A-DAD0CDAC8E7FQ42804790-A681F3AF-3485-41CC-8320-737D8C2D29F2
P2860
The epithelium in idiopathic pulmonary fibrosis: breaking the barrier.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The epithelium in idiopathic pulmonary fibrosis: breaking the barrier.
@en
type
label
The epithelium in idiopathic pulmonary fibrosis: breaking the barrier.
@en
prefLabel
The epithelium in idiopathic pulmonary fibrosis: breaking the barrier.
@en
P2093
P2860
P356
P1476
The epithelium in idiopathic pulmonary fibrosis: breaking the barrier.
@en
P2093
Ana Camelo
Deborah L Clarke
Matthew A Sleeman
Rebecca Dunmore
P2860
P356
10.3389/FPHAR.2013.00173
P577
2014-01-10T00:00:00Z